Split History
HTGM split history picture
HTG Molecular Diagnostics (HTGM) has 1 split in our HTGM split history database. The split for HTGM took place on November 23, 2020. This was a 1 for 15 reverse split, meaning for each 15 shares of HTGM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.

When a company such as HTG Molecular Diagnostics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the HTGM split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into HTG Molecular Diagnostics shares, starting with a $10,000 purchase of HTGM, presented on a split-history-adjusted basis factoring in the complete HTGM split history. HTGM split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/07/2015
End date: 09/27/2022
Start price/share: $209.10
End price/share: $0.62
Dividends collected/share: $0.00
Total return: -99.70%
Average Annual Total Return: -54.50%
Starting investment: $10,000.00
Ending investment: $29.53
Years: 7.40
HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay;HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel. According to our HTGM split history records, HTG Molecular Diagnostics has had 1 split.
Date Ratio
11/23/20201 for 15
HTGM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

IART Split History
IBIO Split History
ICAD Split History
ICCC Split History
ICLR Split History
ICUI Split History
IDRA Split History
IDXG Split History
IDXX Split History
IGC Split History

Also explore: HTGM shares outstanding history

Email EnvelopeFree HTGM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

HTGM Insider Buying

HTGM Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.